Treace Medical Concepts (TMCI) Other Accumulated Expenses (2020 - 2026)
Treace Medical Concepts (TMCI) posted Other Accumulated Expenses of $2.3 million for Q1 2026, up 3.94% on a QoQ basis from $2.2 million in Q4 2025, and down 28.63% year-over-year from $3.2 million in Q1 2025.
Treace Medical Concepts (TMCI) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- Quarterly Other Accumulated Expenses fell 28.63% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 28.63% YoY) and the FY2025 annual result came in at $2.2 million, up 6.18% from the prior year.
- Other Accumulated Expenses was $2.3 million for Q1 2026 at Treace Medical Concepts, up from $2.2 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $4.5 million in Q1 2024 and bottomed at $1.5 million in Q1 2022.
- A 5-year average of $2.9 million and a median of $2.8 million in 2025 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses surged 144.41% — and 2024, when it tumbled 48.24%.
- Treace Medical Concepts' Other Accumulated Expenses stood at $1.8 million in 2022, then surged by 123.4% to $4.0 million in 2023, then plunged by 48.24% to $2.1 million in 2024, then climbed by 6.18% to $2.2 million in 2025, then climbed by 3.94% to $2.3 million in 2026.
- Business Quant data shows TMCI's Other Accumulated Expenses at $2.3 million in Q1 2026, $2.2 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn |
| 10 | Treace Medical Concepts | 262.57 Mn | 210.72 Mn | 37.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.27 Mn |
| Dec 31, 2025 | 2.18 Mn |
| Sep 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Mar 31, 2025 | 3.18 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | 3.06 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 4.49 Mn |
| Dec 31, 2023 | 3.97 Mn |
| Sep 30, 2023 | 4.13 Mn |
| Jun 30, 2023 | 4.00 Mn |
| Mar 31, 2023 | 3.65 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 2.12 Mn |
| Jun 30, 2022 | 2.54 Mn |
| Mar 31, 2022 | 1.49 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Dec 31, 2020 | 441,000.00 |